Nuvectis Pharma Inc (NVCT)

10:40 AM

Is Nuvectis Pharma Inc a good long term investmentStock Split Announcements & High Yield Market Growth - earlytimes.in

10:40 AM

08:45 AM

Why Nuvectis Pharma Inc. stock remains undervaluedEarnings Summary Report & Fast Moving Trade Plans - newser.com

08:45 AM

05:06 AM

How strong is Nuvectis Pharma Inc. stock revenue growthJuly 2025 Short Interest & Weekly Return Optimization Alerts - newser.com

05:06 AM

03:12 AM

How Nuvectis Pharma Inc. stock performs in rate cut cyclesJuly 2025 Sector Moves & Community Consensus Trade Alerts - newser.com

03:12 AM

01:41 AM

Using RSI to spot recovery in Nuvectis Pharma Inc.July 2025 Spike Watch & Capital Protection Trading Alerts - newser.com

01:41 AM

Nov 02, 2025

Predicting Nuvectis Pharma Inc. trend using moving averagesJuly 2025 Recap & Entry Point Confirmation Signals - newser.com

Nov 02, 2025

Nov 02, 2025

What makes Nuvectis Pharma Inc. stock attractive to growth funds2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com

Nov 02, 2025

Nov 01, 2025

Nuvectis Pharma Shares: Poised for Significant Growth? - AD HOC NEWS

Nov 01, 2025

Oct 31, 2025

Nuvectis Pharma : Initial Statement of Beneficial Ownership (Form 3) - MarketScreener

Oct 31, 2025

Oct 31, 2025

What data driven models say about Nuvectis Pharma Inc.’s futureMarket Volume Summary & Smart Investment Allocation Insights - newser.com

Oct 31, 2025

Oct 31, 2025

Does Nuvectis Pharma Inc. qualify in momentum factor screening2025 Price Momentum & Advanced Technical Signal Analysis - newser.com

Oct 31, 2025

Oct 30, 2025

Insider Buying: Nuvectis Pharma (NASDAQ:NVCT) Major Shareholder Acquires 46,900 Shares of Stock - MarketBeat

Oct 30, 2025

Oct 30, 2025

Insider Buying: Nuvectis Pharma (NASDAQ:NVCT) Major Shareholder Purchases 72,836 Shares of Stock - MarketBeat

Oct 30, 2025

Oct 30, 2025

A US$22m Market Cap Boost Pleasing ToNuvectis Pharma Insiders - simplywall.st

Oct 30, 2025

Oct 30, 2025

What's Driving Renewed Interest In Nuvectis Pharma's Oncology Strategy? - RTTNews

Oct 30, 2025

Oct 29, 2025

Major Investment Alert: Insider Buys Big in Nuvectis Pharma! - TipRanks

Oct 29, 2025

Oct 29, 2025

Insider Stock Purchases: October 29, 2025 - Quiver Quantitative

Oct 29, 2025

Oct 29, 2025

Nuvectis Pharma Stock (NVCT) Opinions on NXP900 Trial Results - Quiver Quantitative

Oct 29, 2025

Oct 29, 2025

Nuvectis Pharma (NVCT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Oct 29, 2025

Oct 29, 2025

Nuvectis Pharma Insider Bought Shares Worth $957,083, According to a Recent SEC Filing - MarketScreener

Oct 29, 2025

Oct 28, 2025

Nuvectis Pharma’s Phase 1 Study of NXP900: A Potential Game-Changer in Cancer Treatment - The Globe and Mail

Oct 28, 2025

Oct 28, 2025

Can Nuvectis Pharma Inc. stock hit analyst price targetsMarket Volume Summary & Daily Technical Forecast Reports - fcp.pa.gov.br

Oct 28, 2025

Oct 28, 2025

H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target - Investing.com Nigeria

Oct 28, 2025

Oct 28, 2025

H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target By Investing.com - Investing.com South Africa

Oct 28, 2025

Oct 28, 2025

Can Nuvectis Pharma Inc. stock reach $100 price targetJuly 2025 Institutional & Free Technical Pattern Based Buy Signals - fcp.pa.gov.br

Oct 28, 2025

Oct 28, 2025

Will Nuvectis Pharma Inc. stock beat EPS estimatesWatch List & Consistent Growth Equity Picks - newser.com

Oct 28, 2025

Oct 27, 2025

Nuvectis Pharma Inc. stock trendline breakdownJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com

Oct 27, 2025

Oct 27, 2025

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - The Manila Times

Oct 27, 2025

Oct 27, 2025

Nuvectis (NASDAQ: NVCT): NXP900 PD ≥150 mg/day; Phase 1b underway; no CYP450 induction - Stock Titan

Oct 27, 2025